Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration
Junjie Chen, … , Tzung K. Hsiai, René R. Sevag Packard
Junjie Chen, … , Tzung K. Hsiai, René R. Sevag Packard
Published April 18, 2019
Citation Information: JCI Insight. 2019;4(8):e125362. https://doi.org/10.1172/jci.insight.125362.
View: Text | PDF
Resource and Technical Advance Cardiology

Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration

  • Text
  • PDF
Abstract

Zebrafish are increasingly utilized to model cardiomyopathies and regeneration. Current methods evaluating cardiac function have known limitations, fail to reliably detect focal mechanics, and are not readily feasible in zebrafish. We developed a semiautomated, open-source method — displacement analysis of myocardial mechanical deformation (DIAMOND) — for quantitative assessment of 4D segmental cardiac function. We imaged transgenic embryonic zebrafish in vivo using a light-sheet fluorescence microscopy system with 4D cardiac motion synchronization. Our method permits the derivation of a transformation matrix to quantify the time-dependent 3D displacement of segmental myocardial mass centroids. Through treatment with doxorubicin, and by chemically and genetically manipulating the myocardial injury–activated Notch signaling pathway, we used DIAMOND to demonstrate that basal ventricular segments adjacent to the atrioventricular canal display the highest 3D displacement and are also the most susceptible to doxorubicin-induced injury. Thus, DIAMOND provides biomechanical insights into in vivo segmental cardiac function scalable to high-throughput research applications.

Authors

Junjie Chen, Yichen Ding, Michael Chen, Jonathan Gau, Nelson Jen, Chadi Nahal, Sally Tu, Cynthia Chen, Steve Zhou, Chih-Chiang Chang, Jintian Lyu, Xiaolei Xu, Tzung K. Hsiai, René R. Sevag Packard

×

Figure 5

The 3D cardiac trabecular architecture in response to doxorubicin-induced injury and genetic manipulation.

Options: View larger image (or click on image) Download as PowerPoint
The 3D cardiac trabecular architecture in response to doxorubicin-induce...
(A) Diagram depicting the experimental schedule. (B–D) Light-sheet imaging–acquired 3D trabecular network for quantitative analyses. Compact myocardium (blue) and trabeculated myocardium (red) were manually segmented. (E–G) Representative 3D reconstructed images reveal a significant reduction of the trabecular network in the groups treated with doxorubicin and doxorubicin + γ-secretase inhibitor (DAPT) at 4 dpf. (H–M) Microinjection of the Notch downstream effectors Notch intracellular domain (NICD) and neuregulin-1 (NRG1) mRNA rescued the DAPT-attenuated trabecular network at 4 dpf. (N and O) Quantitative analysis of trabecular volume normalized to total myocardium volume at 4 and 6 dpf (ANOVA, *P < 0.05, **P < 0.01, n = 5–10 per group). Scale bars: 25 μm.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts